Align Technology completes acquisition of Cubicure, a pioneer of direct 3D printing solutions for polymer additive manufacturing
Align continues to innovate and invest in technologies that enable the next generation of direct 3D printed products,…
Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
- Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per share
- Following the close…
Biomay Announces Expansion of its GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
Biomay, a Vienna based biotech manufacturer, announced a facility extension and is now able to expand its…
Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ®
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug…
HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
- New funds committed to market-ready development of HeartBeat.bio’s unique 3D human tissue-based Cardioid Drug…
Groundbreaking: Takeda builds lab of the future in Vienna
Together with high-ranking representatives from government, business and academia, Takeda today held a symbolic…
Spatenstich in Wien-Favoriten: Octapharma baut Produktionsstandort stark aus
• Erweiterung Haberkornhalle wichtiger Meilenstein im Ausbauprogramm
• Produktionserweiterung, um Wachstumserwartungen…
Vienna-based PIUR IMAGING secures €4.9 Million to expand its AI-driven tomographic 3D to the US
PIUR IMAGING, a medical device company that enables access to affordable high-quality healthcare through AI-driven…
contextflow approved for EIC Accelerator Equity Investment
We are beyond thrilled to announce that contextflow’s application for the European Innovation Council (EIC) Accelerator…
Vienna-based nyra health raises €4.5 million in Seed to further advance its digital neuro-therapy
Nyra Health: "We are thrilled to officially announce our oversubscribed 4.5m seed round co-led by MassMutual Ventures…
Boehringer Ingelheim feiert Dachgleiche beim neuen Krebsforschungsgebäude
Nach dem Baubeginn im Juli letzten Jahres setzt Boehringer Ingelheim einen Meilenstein beim Bau des neuen…
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
HOOKIPA Pharma Inc. (Nasdaq: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its…